Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938599 · ClinicalTrials.gov registry record · Phase 2
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Phase 2 study, sponsored by AmDerma.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT01938599 is a Phase 2 study that has completed, run by AmDerma. The registered enrollment target is 92 participants.
The verdict
NCT01938599, a Phase 2 study, has completed, sponsored by AmDerma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
To compare the safety and efficacy profile of AM001 Cream and its vehicle in the treatment of plaque psoriasis.
Interventions
- DRUG AM001 Cream, 7.5%
- DRUG Placebo of AM001 Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938599
The ClinicalTrials.gov registry entry for NCT01938599 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AmDerma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AM001 Cream, 7.5% is the first listed.
NCT01938599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938599 about?
NCT01938599 is a clinical study titled "Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis". To compare the safety and efficacy profile of AM001 Cream and its vehicle in the treatment of plaque psoriasis.
What is the current status of trial NCT01938599?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2013-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01938599?
The interventions under investigation include: AM001 Cream, 7.5% (DRUG), Placebo of AM001 Cream (DRUG).
Who is sponsoring clinical trial NCT01938599?
This trial is sponsored by AmDerma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.